Lantidra Market Report 2026
Download Free Sample Buy Now
Lantidra Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Lantidra Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Lantidra Market Overview

• The Lantidra market growth in the historic period has been driven by advances in pancreatic cell biology, unmet needs in type 1 diabetes management

• Market expansion is supported by expansion of curative diabetes treatment research, increasing adoption of cell therapies in endocrinology

• Growth Driver: Rising Prevalence Of Type-1 Diabetes Driving The Market Growth

• Market Trend: Advancements In Allogeneic Pancreatic Islet Cellular Therapy For Type 1 Diabetes Management

• North America was the largest region in 2025.

What Is Covered Under Lantidra Market?

Lantidra is a cell-based therapy designed to treat type 1 diabetes by using genetically modified donor pancreas cells to restore natural insulin production. It reduces or eliminates the need for external insulin injections, improving blood sugar control. Its goal is to replace the pancreas function, offering a more sustainable option and enhancing the quality of life for insulin-dependent patients.

The main types of lantidra formulation are injectable formulation (subcutaneous) and pre-filled syringes, or auto-injectors. Injectable formulation (subcutaneous) delivers medication under the skin for gradual absorption, offering controlled release and easy self-administration for chronic conditions. It is applicable in various indications, such as the delay of clinical type 1 diabetes, prevention of type 1 diabetes, and treatment of newly diagnosed type 1 diabetes for several patient demographics, including pediatric patients, adult patients, and geriatric patients. It is distributed through various distribution channels, such as direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and used by several end users, including hospitals, specialty clinics, home healthcare providers, and research institutions.

Lantidra Market Global Report 2026 Market Report bar graph

What Is The Lantidra Market Size and Share 2026?

The growth in the historic period can be attributed to advances in pancreatic cell biology, unmet needs in type 1 diabetes management, progress in cell encapsulation technologies, increased investment in regenerative medicine, early clinical success of cell therapies.

What Is The Lantidra Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of curative diabetes treatment research, increasing adoption of cell therapies in endocrinology, advancements in immune protection strategies, rising focus on long-term glucose control solutions, supportive regulatory frameworks for cell therapies. Major trends in the forecast period include increasing development of cell-based diabetes therapies, expansion of regenerative medicine approaches, growing focus on insulin independence solutions, rising integration of gene-modified cell platforms, enhanced patient quality of life outcomes.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Lantidra Market Segmentation

1) By Formulation: Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors

2) By Indication: Delay Of Clinical Type 1 Diabetes, Prevention Of Type 1 Diabetes, Treatment Of Newly Diagnosed Type 1 Diabetes

3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Specialty Clinics, Home Healthcare Providers, Research Institutions

What Are The Drivers Of The Lantidra Market?

The rising prevalence of type-1 diabetes is expected to propel the growth of the lantidra market going forward. Type-1 diabetes refers to a chronic condition where the immune system attacks the insulin-producing cells in the pancreas, leading to a lack of insulin and requiring lifelong insulin therapy for blood sugar regulation. The prevalence of Type 1 diabetes is attributed to factors such as genetic predisposition, environmental triggers such as viral infections, immune system malfunctions, and improved diagnostic capabilities. Lantidra involves transplanting insulin-producing cells from donated pancreas to restore natural insulin production in type 1 diabetes patients. This treatment improves blood sugar control, reduces insulin dependence, and may lower the risk of complications. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%. Therefore, the rising prevalence of type-1 diabetes drives the lantidra industry growth.

The rising healthcare spending is significantly driving the growth of the lantidra market going forward. Healthcare spending encompasses the overall financial outlay for healthcare services, covering medical treatments, hospital services, pharmaceuticals, and healthcare infrastructure. Healthcare spending rises due to factors such as an aging population, increasing prevalence of chronic diseases, advancements in medical technology, and greater demand for healthcare services. Rising healthcare spending boosts investment in advanced treatments such as Lantidra, which offers improved outcomes and long-term savings. This funding enhances access to innovative therapies across broader regions and patient groups. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based Institute for Health Information, total health spending in Canada is projected to reach $344 billion in 2023, equating to $8,740 per person. This marks a 2.8% increase compared to the 2022. Therefore, the rising healthcare spending is driving the lantidra industry growth.

Key Players In The Global Lantidra Market

Major companies operating in the lantidra market are CellTrans Inc.

Global Lantidra Market Trends and Insights

The key trend of the lantidra market is developing advanced therapies such as allogeneic (donor) pancreatic islet cellular therapy to improve the management of type 1 diabetes by reducing the dependence on insulin injections. Allogeneic (donor) pancreatic islet cellular therapy involves transplanting insulin-producing islet cells from a healthy donor into a recipient. This therapy helps restore insulin production in individuals with type 1 diabetes who have lost this function due to damaged pancreatic cells. For instance, in June 2023, CellTrans Inc., a US-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for Lantidra to provide insulin-producing beta cells, offering a potential solution for patients with severe hypoglycemia and insulin dependency. It is administered via a single infusion into the liver's portal vein, and Lantidra may reduce or eliminate the need for insulin injections in some patients. The therapy is approved with patient-directed labeling, highlighting both benefits and risks, including the need for immunosuppressive medications to maintain islet cell function.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the lantidra market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Lantidra Market?

The lantidra market consists of sales of genetically modified donor pancreas cells, cell transplantation, and immune suppression drugs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lantidra Market Report 2026?

The lantidra market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lantidra industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Lantidra Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Formulation, Indication, Patient Demographics, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled CellTrans Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lantidra Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lantidra Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lantidra Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lantidra Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Development Of Cell-Based Diabetes Therapies

4.2.2 Expansion Of Regenerative Medicine Approaches

4.2.3 Growing Focus On Insulin Independence Solutions

4.2.4 Rising Integration Of Gene-Modified Cell Platforms

4.2.5 Enhanced Patient Quality Of Life Outcomes

5. Lantidra Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Endocrinology Centers

5.4 Home Healthcare Providers

5.5 Research Institutions

6. Lantidra Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lantidra Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lantidra PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lantidra Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lantidra Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lantidra Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lantidra Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lantidra Market Segmentation

9.1. Global Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors

9.2. Global Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Delay Of Clinical Type 1 Diabetes, Prevention Of Type 1 Diabetes, Treatment Of Newly Diagnosed Type 1 Diabetes

9.3. Global Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Patients, Adult Patients, Geriatric Patients

9.4. Global Lantidra Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

9.5. Global Lantidra Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Home Healthcare Providers, Research Institutions

10. Lantidra Market Regional And Country Analysis

10.1. Global Lantidra Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lantidra Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lantidra Market

11.1. Asia-Pacific Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lantidra Market

12.1. China Lantidra Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lantidra Market

13.1. India Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lantidra Market

14.1. Japan Lantidra Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lantidra Market

15.1. Australia Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Lantidra Market

16.1. South Korea Lantidra Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Lantidra Market

17.1. Western Europe Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Lantidra Market

18.1. UK Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Lantidra Market

19.1. Germany Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Lantidra Market

20.1. France Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Lantidra Market

21.1. Eastern Europe Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Lantidra Market

22.1. North America Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Lantidra Market

23.1. USA Lantidra Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Lantidra Market

24.1. Canada Lantidra Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Lantidra Market

25.1. South America Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Lantidra Market

26.1. Middle East Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Lantidra Market

27.1. Africa Lantidra Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Lantidra Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Lantidra Market Regulatory and Investment Landscape

29. Lantidra Market Competitive Landscape And Company Profiles

29.1. Lantidra Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Lantidra Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Lantidra Market Company Profiles

29.3.1. CellTrans Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Lantidra Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Lantidra Market

32. Lantidra Market High Potential Countries, Segments and Strategies

32.1 Lantidra Market In 2030 - Countries Offering Most New Opportunities

32.2 Lantidra Market In 2030 - Segments Offering Most New Opportunities

32.3 Lantidra Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Lantidra Market, Overview Of Key Products - Product Examples
  • Table 2: Global Lantidra Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Lantidra Market, Supply Chain Analysis
  • Table 4: Global Lantidra Market, Major Raw Material Providers
  • Table 5: Global Lantidra Market, Major Resource Providers
  • Table 6: Global Lantidra Market, Major Manufacturers (Suppliers)
  • Table 7: Global Lantidra Market, Major Distributors And Channel Partners
  • Table 8: Global Lantidra Market, Key Technologies & Future Trends
  • Table 9: Global Lantidra Market, Major Trends
  • Table 10: Global Lantidra Market, Major End Users
  • Table 11: Global Lantidra Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Lantidra Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Lantidra Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Lantidra Market - TAM, US$ Billion, 2025
  • Table 15: Global Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Lantidra Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Lantidra Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Lantidra Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Lantidra Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Western Europe, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: UK, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Germany, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: France, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Eastern Europe, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: North America, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: USA, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Canada, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: South America, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Middle East, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Africa, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Global Lantidra Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 74: Global Lantidra Market - Company Scoring Matrix
  • Table 75: CellTrans Inc. Financial Performance
  • Table 76: Global Lantidra Market, Competitive Benchmarking (In USD Billions)
  • Table 77: Global Lantidra Market, Competitive Dashboard
  • Table 78: Global Lantidra Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 79: Global, Lantidra Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 80: Global, Lantidra Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 81: Global, Lantidra Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

    Figure 1: Global Lantidra Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Lantidra Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Lantidra Market, Supply Chain Analysis
  • Figure 4: Global Lantidra Market, Major Raw Material Providers
  • Figure 5: Global Lantidra Market, Major Resource Providers
  • Figure 6: Global Lantidra Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Lantidra Market, Major Distributors And Channel Partners
  • Figure 8: Global Lantidra Market, Key Technologies & Future Trends
  • Figure 9: Global Lantidra Market, Major Trends
  • Figure 10: Global Lantidra Market, Major End Users
  • Figure 11: Global Lantidra Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Lantidra Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Lantidra Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Lantidra Market - TAM, US$ Billion, 2025
  • Figure 15: Global Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Lantidra Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Lantidra Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Lantidra Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Lantidra Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Western Europe, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: UK, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Germany, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: France, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Eastern Europe, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: North America, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: USA, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Canada, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: South America, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Middle East, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Lantidra Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Lantidra Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Africa, Lantidra Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Global Lantidra Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 74: Global Lantidra Market - Company Scoring Matrix
  • Figure 75: CellTrans Inc. Financial Performance
  • Figure 76: Global Lantidra Market, Competitive Benchmarking (In USD Billions)
  • Figure 77: Global Lantidra Market, Competitive Dashboard
  • Figure 78: Global Lantidra Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 79: Global, Lantidra Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 80: Global, Lantidra Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 81: Global, Lantidra Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Oral Biologics & Biosimilar Drugs Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, ...

Microbiome Market Report 2026 - Global Outlook – By Microbe Category (Bacteria, Archaea, Viruses, Other Microbiomes), By Product (Therapeutics, Diagnostics), By Technology (Genomics, Proteomics, Metabolomics), By End-Use...

Frequently Asked Questions

The Lantidra market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Lantidra market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Lantidra market Include, CellTrans Inc. .

Major trend in this market includes: Advancements In Allogeneic Pancreatic Islet Cellular Therapy For Type 1 Diabetes Management. For further insights on this market. request a sample here

North America was the largest region in the lantidra market in 2025. The regions covered in the lantidra market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us